Impax Laboratories (IPXL) Tops Q2 EPS by 3c, Revenue Beats Expectations
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q2 EPS of $0.22, $0.03 better than the analyst estimate of $0.19. Revenue for the quarter came in at $125.9 million versus the consensus estimate of $110.94 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
- Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
